Kythera Investor Challenges $2B Sale To Allergan
A Kythera Biopharmaceuticals Inc. investor launched a putative class action in Delaware Chancery Court on Friday, challenging Kythera's proposed $2.1 billion buyout by Irish drugmaker Allergan PLC, saying that the deal...To view the full article, register now.
Already a subscriber? Click here to view full article